Modifier genes convert 'simple' Mendelian disorders to complex traits

Molecular Genetics and Metabolism

Volumn 71, Issue 1-2, 2000, Pages 43-50

  Dipple, Katrina M ^a   McCabe, Edward R B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adrenal hypoplasia congenita; Complex traits; Craniosynostosis; Cystic fibrosis; Genotype phenotype correlations; Hirschsprung disease; Mendelian disorders; Modifier genes; Neurofibromatosis type 2

Indexed keywords

ENDOTHELIN 3; ENDOTHELIN RECEPTOR; FIBROBLAST GROWTH FACTOR 3; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; TRANSMEMBRANE CONDUCTANCE REGULATOR; TYROSINE KINASE RECEPTOR;

ADRENAL CORTEX INSUFFICIENCY; CRANIOFACIAL SYNOSTOSIS; CYSTIC FIBROSIS; GENE; GENETIC ANALYSIS; GENETIC DISORDER; GENOTYPE; HIRSCHSPRUNG DISEASE; HUMAN; MULTIFACTORIAL INHERITANCE; NEUROFIBROMATOSIS; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0033799531     PISSN: 10967192     EISSN: None     Source Type: Journal    
DOI: 10.1006/mgme.2000.3052     Document Type: Article

References (79)

1. Phenotypes of patients with 'simple' Mendelian disorders are complex traits: Thresholds, modifiers and systems dynamics
2. Cystic fibrosis
3. A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations
4. A missense cystic fibrosis transmembrane conductance regulator mutation with variable phenotype
5. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13
6. The genesis of cystic fibrosis lung disease
7. 508)
8. Two patients with cystic fibrosis, nonsense mutations in each cystic fibrosis gene, and mild pulmonary disease
9. A cystic fibrosis patient homozygous for the nonsense mutation R553X
10. Nine cystic fibrosis patients homozygous for the CFTR nonsense mutation R1162X have mild or moderate lung disease
11. A mutation in CFTR produces different phenotypes depending on chromosomal background
12. Severe cystic fibrosis in a child homozygous for the G542 nonsense mutation in the CFTR gene
13. Severe pulmonary and digestive disease in a cystic fibrosis child homozygous for G542X
14. Clinical and genetic risk factors for cystic fibrosis-related liver disease
15. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
16. The Lebanese allele at the low density lipoprotein receptor locus: Nonsense mutation produces truncated receptor that is retained in endoplasmic reticulum
17. Monogenic traits are not simple: Lessons from phenylketonuria
18. The molecular basis of partial penetrance of splicing mutations in cystic fibrosis
19. Determinants of mild clinical symptoms in cystic fibrosis patients: Residual chloride secretion measured in rectal biopsies in relation to the genotype
20. In vivo measurements of ion transport in long-living CF mice
21. Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor
22. Clinical and genetic comparisons of patients with cystic fibrosis, with or without meconium ileus
23. Genetic determination of exocrine pancreatic function in cystic fibrosis
24. Correlation between genotype and phenotype in patients with cystic fibrosis
25. HLA class II polymorphism in cystic fibrosis: A possible modifier of pulmonary phenotype
26. Association of cystic fibrosis with allergy
27. Atopy and bronchial reactivity in older patients with cystic fibrosis
28. HLA class II antigens and T lymphocytes in human nasal epithelial cells. Modulation of the HLA class II gene transcripts by gamma interferon
29. Prognosis in cystic fibrosis
30. Emergence and persistence of pseudomonas aeruginosa in the cystic fibrosis airway
31. Relationship between socioeconomic status and disease severity in cystic fibrosis
32. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
33. Role of polyunsaturated fatty acids in lung disease
34. Hirschsprung's disease genes and the development of the enteric nervous system
35. A human model for multigenic inheritance: Phenotypic expression in Hirschsprung disease requires both the RET gene and a new 9q31 locus
36. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease
37. Severe phenotype of neurofibromatosis type 2 in a patient with a 7.4-mb constitutional deletion on chromosome 22: Possible localization of a neurofibromatosis type 2 modifier gene?
38. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor
39. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2
40. Screening for germ line mutations in the NF2 gene
41. Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease
42. Germ-line mutations in the neurofibromatosis 2 gene: Correlations with disease severity and retinal abnormalities
43. Identification of NF2 germ-line mutations and comparison with neurofibromatosis 2 phenotypes
44. Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): Evidence for more severe disease associated with truncating mutations
45. A mutation in the neurofibromatosis type 2 tumor-suppressor gene, giving rise to widely different clinical phenotypes in two unrelated individuals
46. A missense mutation in the neurofibromatosis 2 gene occurs in patients with mild and severe phenotypes
47. A missense mutation in the NF2 gene results in moderate and mild clinical phenotypes of neurofibromatosis type 2
48. Germline deletion in a neurofibromatosis type 2 kindred inactivates the NF2 gene and a candidate meningioma locus
49. A disease-associated germline deletion maps to the type 2 neurofibromatosis (NF2) gene between the Ewing sarcoma region and the leukemia inhibitory factor locus
50. Sex related expressivity of the phenotype in coronal craniosynostosis caused by the recurrent P250R FGFR3 mutation
51. Deafness due to Pro250Arg mutation of FGFR3
52. Adrenal hypoplasias and aplasias
53. Congenital adrenal hypoplasia
54. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita
55. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism
56. Diagnosis of X-linked adrenal hypoplasia congenita by mutation analysis of the DAX1 gene
57. SRVX, a sex reversing locus in Xp21.2 to p22.11
58. A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal
59. Dax1 antagonizes Sry action in mammalian sex determination
60. Mammalian sex determination: From gonads to brain
61. Expression of DAX-1, the gene responsible for X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism, in the hypothalmic-pituitary-adrenal/gonadal axis
62. Characterization of the mouse DAX-1 gene reveals evolutionary conservation of a unique amino-terminal motif and widespread expression in mouse tissue
63. Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function
64. Hypothalamic hypogonadism in congenital adrenal hypoplasia
65. Congenital adrenal hypoplasia and isolated gonadotropin deficiency
66. Adrenal hypoplasia congenita with hypogonadotropic hypogonadism: Evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production
67. Sex and the single DAX1: Too little is bad, but can we have too much?
68. Familial X-linked adrenocortical hypoplasia association with androgenic precocity
69. Identification of a putative steroidogenic factor-1 response element in the DAX-1 promoter
70. DAX1 gene expression upregulated by steroidogenic factor 1 in an adrenocortical carcinoma cell line
71. DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita
72. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1
73. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita
74. Interaction of the corepressor alien with DAX-1 is abrogated by mutations of DAX-1 involved in adrenal hypoplasia congenita
75. Wilms' Tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression
76. A mutation in the gene encoding steroidogenic factor-1 causes XY sex reversal and adrenal failure in humans
77. The roles of the nuclear hormone receptor steroidogenic factor 1 in endocrine differentiation and development
78. DAX1 and related orphan receptors
79. The rise and fall of positional cloning?